News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Biologic Products Reports Two SFDA Successes



5/1/2008 2:13:34 PM

May 1, 2008 -- China Biologic Products, Inc. (OTCBB: CBPO) received SFDA approval to start the production of Cryoprecipitate, a frozen blood product prepared from plasma, and also to begin a clinical trial of Human Prothrombin Complex, a new offering. China Biologic bases its business on plasma-derived biopharmaceuticals. Its human albumin products are used to increase blood volume and its immunoglobulin products treat and prevent diseases. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES